Royal College of Radiologists. Letter to the Secretary of State for Health and Social Care – Capacity challenges in oncology departments preventing the effective delivery of cancer drugs. Available from: https://www.rcr.ac.uk/sites/default/files/letter1.pdf (18th May 2023, accessed 04 June 2023).
3.
PricePSullivanRAhmedA,et al.UK cancer care: a watershed moment and the need for urgent intervention. Lancet Oncol2023; 24: 133–138.
4.
GourdE. Concern over cancer treatment delays caused by staffing shortages. Lancet Oncol2023; S1470-2045: 00267X.
5.
NgWDodhiaVShahY, et al.Service evaluation of the pharmacist independent prescribing clinics at a cancer centre. J Oncol Pharm Pract2022; 28: 47–48.
6.
Barron G, Dodhia V, Ng W, et al. Empowering pharmacy technicians to embrace a more advanced role in cancer care. J Oncol Pharm Pract 2023; 29: 84.
FothergillLJAl-OraibiAHoudmontJ, et al.Nationwide evaluation of the advanced clinical practitioner role in England: a cross-sectional survey. BMJ Open2022; 12: e055475.
ShakespeareJParkesEBryceM,et al.Advanced roles in respiratory healthcare science: it’s not just spirometry. Breathe (Sheff)2019; 15: 267–269.
14.
National Health Service England and National Health Service Improvement. Investing in chief allied health professionals: insights from trust executives – a guide to reviewing AHP leadership for trust boards and clinicians. Available from: https://www.england.nhs.uk/wp-content/uploads/2021/08/investing-in-chief-ahp-leadership.pdf (July 2019, accessed 04 June 2023)
NgHWDodhiaVAlvesC, et al.Joint working between NHS & commercial sector to promote self-administration of subcutaneous systemic anti-cancer therapy (SACT) in breast cancer patients: a patients’ perspective. J Oncol Pharm Pract2023; 29: 51–52.
17.
NgHWDodhiaVAlvesC,et al.Preference of subcutaneous trastuzumab & pertuzumab (Phesgo®) versus conventional intravenous infusions in breast cancer patients. J Oncol Pharm Pract2022; 28: 33–34.